Puya Gharahkhani1, Kathryn P Burdon2, Alex W Hewitt3, Matthew H Law1, Emmanuelle Souzeau4, Grant W Montgomery1, Graham Radford-Smith5, David A Mackey6, Jamie E Craig7, Stuart MacGregor1. 1. Queensland Institute of Medical Research Berghofer Medical Research Institute Brisbane, Queensland, Australia. 2. Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia 3Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. 3. Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia 4Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia. 4. Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia. 5. Queensland Institute of Medical Research Berghofer Medical Research Institute Brisbane, Queensland, Australia 5School of Medicine, University of Queensland, Herston Campus, Brisbane, Queensland, Australia. 6. Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia 6Centre for Ophthalmology and Visual Science, Lions Eye Institute, University of Western Australia, Perth, Western Australia, Australia. 7. Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia 7South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
Abstract
PURPOSE: Myocilin (MYOC) is a well-established primary open-angle glaucoma (POAG) risk gene, with rare variants known to have high penetrance. The most common clinically relevant risk variant, Gln368Ter, has an allele frequency of 0.1% to 0.3% in populations of European ancestry. Detection of rare MYOC variants has traditionally been conducted using Sanger sequencing. Here we report the use of genotyping arrays and imputation to assess whether rare variants including Gln368Ter can be reliably detected. METHODS: A total of 1155 cases with advanced POAG and 1992 unscreened controls genotyped on common variant arrays participated in this study. Accuracy of imputation of Gln368Ter variants was compared with direct sequencing. A genome-wide association study was performed using additive model adjusted for sex and the first six principal components. RESULTS: We found that although the arrays we used were designed to tag common variants, we could reliably impute the Gln368Ter variant (rs74315329). When tested in 1155 POAG cases and 1992 controls, rs74315329 was strongly associated with risk (odds ratio = 15.53, P = 1.07 × 10-9). All POAG samples underwent full sequencing of the MYOC gene, and we found a sensitivity of 100%, specificity of 99.91%, positive predictive value of 95.65%, and negative predictive value of 100% between imputation and sequencing. Gln368Ter was also accurately imputed in a further set of 1801 individuals without POAG. Among the total set of 3793 (1992 + 1801) individuals without POAG, six were predicted (probability > 95%) to carry the risk variant. CONCLUSIONS: We demonstrate that some clinically important rare variants can be reliably detected using arrays and imputation. These results have important implications for the detection of clinically relevant incidental findings in ongoing and future studies using arrays.
PURPOSE:Myocilin (MYOC) is a well-established primary open-angle glaucoma (POAG) risk gene, with rare variants known to have high penetrance. The most common clinically relevant risk variant, Gln368Ter, has an allele frequency of 0.1% to 0.3% in populations of European ancestry. Detection of rare MYOC variants has traditionally been conducted using Sanger sequencing. Here we report the use of genotyping arrays and imputation to assess whether rare variants including Gln368Ter can be reliably detected. METHODS: A total of 1155 cases with advanced POAG and 1992 unscreened controls genotyped on common variant arrays participated in this study. Accuracy of imputation of Gln368Ter variants was compared with direct sequencing. A genome-wide association study was performed using additive model adjusted for sex and the first six principal components. RESULTS: We found that although the arrays we used were designed to tag common variants, we could reliably impute the Gln368Ter variant (rs74315329). When tested in 1155 POAG cases and 1992 controls, rs74315329 was strongly associated with risk (odds ratio = 15.53, P = 1.07 × 10-9). All POAG samples underwent full sequencing of the MYOC gene, and we found a sensitivity of 100%, specificity of 99.91%, positive predictive value of 95.65%, and negative predictive value of 100% between imputation and sequencing. Gln368Ter was also accurately imputed in a further set of 1801 individuals without POAG. Among the total set of 3793 (1992 + 1801) individuals without POAG, six were predicted (probability > 95%) to carry the risk variant. CONCLUSIONS: We demonstrate that some clinically important rare variants can be reliably detected using arrays and imputation. These results have important implications for the detection of clinically relevant incidental findings in ongoing and future studies using arrays.
Authors: Tayebeh Rezaie; Anne Child; Roger Hitchings; Glen Brice; Lauri Miller; Miguel Coca-Prados; Elise Héon; Theodore Krupin; Robert Ritch; Donald Kreutzer; R Pitts Crick; Mansoor Sarfarazi Journal: Science Date: 2002-02-08 Impact factor: 47.728
Authors: Paul N Baird; Jamie E Craig; Andrea J Richardson; Maree A Ring; Pamela Sim; Sue Stanwix; Simon J Foote; David A Mackey Journal: Hum Genet Date: 2002-11-21 Impact factor: 4.132
Authors: Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham Journal: Am J Hum Genet Date: 2007-07-25 Impact factor: 11.025
Authors: A Angius; P Spinelli; G Ghilotti; G Casu; G Sole; A Loi; A Totaro; L Zelante; P Gasparini; N Orzalesi; M Pirastu; L Bonomi Journal: Arch Ophthalmol Date: 2000-05
Authors: J E Craig; P N Baird; D L Healey; A I McNaught; P J McCartney; J L Rait; J L Dickinson; L Roe; J H Fingert; E M Stone; D A Mackey Journal: Ophthalmology Date: 2001-09 Impact factor: 12.079
Authors: E M Stone; J H Fingert; W L Alward; T D Nguyen; J R Polansky; S L Sunden; D Nishimura; A F Clark; A Nystuen; B E Nichols; D A Mackey; R Ritch; J W Kalenak; E R Craven; V C Sheffield Journal: Science Date: 1997-01-31 Impact factor: 47.728
Authors: Robert J Casson; Glyn Chidlow; John P M Wood; Jonathan G Crowston; Ivan Goldberg Journal: Clin Exp Ophthalmol Date: 2012-04-05 Impact factor: 4.207
Authors: R R Allingham; J L Wiggs; M A De La Paz; D Vollrath; D A Tallett; B Broomer; K H Jones; E A Del Bono; J Kern; K Patterson; J L Haines; M A Pericak-Vance Journal: Invest Ophthalmol Vis Sci Date: 1998-11 Impact factor: 4.799
Authors: Xikun Han; Emmanuelle Souzeau; Jue-Sheng Ong; Jiyuan An; Owen M Siggs; Kathryn P Burdon; Stephen Best; Ivan Goldberg; Paul R Healey; Stuart L Graham; Jonathan B Ruddle; Richard A Mills; John Landers; Anna Galanopoulos; Andrew J R White; Robert Casson; David A Mackey; Alex W Hewitt; Puya Gharahkhani; Jamie E Craig; Stuart MacGregor Journal: JAMA Ophthalmol Date: 2019-01-01 Impact factor: 7.389
Authors: Wallace L M Alward; Carly van der Heide; Cheryl L Khanna; Ben R Roos; Sobha Sivaprasad; Jason Kam; Robert Ritch; Andrew Lotery; Robert P Igo; Jessica N Cooke Bailey; Edwin M Stone; Todd E Scheetz; Young H Kwon; Louis R Pasquale; Janey L Wiggs; John H Fingert Journal: JAMA Ophthalmol Date: 2019-05-01 Impact factor: 7.389
Authors: Guorong Li; Gang Cui; W Michael Dismuke; Iris Navarro; Kristin Perkumas; David F Woodward; W Daniel Stamer Journal: Exp Eye Res Date: 2016-12-07 Impact factor: 3.467
Authors: Puya Gharahkhani; Eric Jorgenson; Pirro Hysi; Anthony P Khawaja; Sarah Pendergrass; Xikun Han; Jue Sheng Ong; Alex W Hewitt; Ayellet V Segrè; John M Rouhana; Andrew R Hamel; Robert P Igo; Helene Choquet; Ayub Qassim; Navya S Josyula; Jessica N Cooke Bailey; Pieter W M Bonnemaijer; Adriana Iglesias; Owen M Siggs; Terri L Young; Veronique Vitart; Alberta A H J Thiadens; Juha Karjalainen; Steffen Uebe; Ronald B Melles; K Saidas Nair; Robert Luben; Mark Simcoe; Nishani Amersinghe; Angela J Cree; Rene Hohn; Alicia Poplawski; Li Jia Chen; Shi-Song Rong; Tin Aung; Eranga Nishanthie Vithana; Gen Tamiya; Yukihiro Shiga; Masayuki Yamamoto; Toru Nakazawa; Hannah Currant; Ewan Birney; Xin Wang; Adam Auton; Michelle K Lupton; Nicholas G Martin; Adeyinka Ashaye; Olusola Olawoye; Susan E Williams; Stephen Akafo; Michele Ramsay; Kazuki Hashimoto; Yoichiro Kamatani; Masato Akiyama; Yukihide Momozawa; Paul J Foster; Peng T Khaw; James E Morgan; Nicholas G Strouthidis; Peter Kraft; Jae H Kang; Chi Pui Pang; Francesca Pasutto; Paul Mitchell; Andrew J Lotery; Aarno Palotie; Cornelia van Duijn; Jonathan L Haines; Chris Hammond; Louis R Pasquale; Caroline C W Klaver; Michael Hauser; Chiea Chuen Khor; David A Mackey; Michiaki Kubo; Ching-Yu Cheng; Jamie E Craig; Stuart MacGregor; Janey L Wiggs Journal: Nat Commun Date: 2021-02-24 Impact factor: 14.919
Authors: Nazlee Zebardast; Sayuri Sekimitsu; Jiali Wang; Tobias Elze; Puya Gharahkhani; Brian S Cole; Michael M Lin; Ayellet V Segrè; Janey L Wiggs Journal: Ophthalmology Date: 2021-03-10 Impact factor: 14.277
Authors: Emmanuelle Souzeau; Kathryn P Burdon; David A Mackey; Alex W Hewitt; Ravi Savarirayan; Margaret Otlowski; Jamie E Craig Journal: Transl Vis Sci Technol Date: 2016-02-09 Impact factor: 3.283
Authors: Christopher DeBoever; Yosuke Tanigawa; Malene E Lindholm; Greg McInnes; Adam Lavertu; Erik Ingelsson; Chris Chang; Euan A Ashley; Carlos D Bustamante; Mark J Daly; Manuel A Rivas Journal: Nat Commun Date: 2018-04-24 Impact factor: 14.919